“The Power of Two: Effective Management of Severe Refractory Psoriasis Through Combined TYK2 and IL-23 Inhibition”, J of Skin, vol. 9, no. 5, pp. 2669–2673, Sep. 2025, doi: 10.25251/kj8rwg98.